Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00921817 · ClinicalTrials.gov registry record

Body Composition in Infants and Children

A clinical trial of Healthy, sponsored by Arkansas Children's Hospital Research Institute.

Completed
Registry status
120
Enrollment target
1
Study location

NCT00921817: Completed study of Healthy, sponsored by Arkansas Children's Hospital Research Institute.

NCT00921817 is a study of Healthy that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 120 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00921817, a study of Healthy, has completed, sponsored by Arkansas Children's Hospital Research Institute.

COMPLETED
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

This study will test a new method for measuring body fat and muscle in infants and children: QMR.

Conditions Studied

Study Locations (1)

Arkansas

  • Arkansas Children's Nutrition Center - Little Rock

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2009-05
Est. Completion 2009-11

What the finished NCT00921817 record still lists

NCT00921817 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT00921817 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT00921817 about?

NCT00921817 is a clinical study titled "Body Composition in Infants and Children". This study will test a new method for measuring body fat and muscle in infants and children: QMR.

What is the current status of trial NCT00921817?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2009-05. Estimated completion is 2009-11.

What conditions does trial NCT00921817 study?

This clinical trial studies the following conditions: Healthy.

Who is sponsoring clinical trial NCT00921817?

This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00921817 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00921817's enrollment target sits among peer trials

120 182nd of 1090 higher than 896 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00921817, the US trial registry maintained by the National Library of Medicine. NCT00921817 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.